In addition, infection-naïve vaccinees with high antibody responses have enriched CD4+ and CD8+ central memory 1 cell responses and durable CD8+ T cell responses to ancestral and VOC S peptides compared to those with low antibody responses and are protected against symptomatic breakthrough infection with Delta or Omicron (35). This evidence concerns the gene CD8A and infection.